Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

OBJECTIVE: To assess the safety and efficacy of etoricoxib, a selective cyclo-oxygenase-2 inhibitor, in comparison with indometacin in the treatment of acute gouty arthritis. DESIGN: Randomised, double blind, active comparator controlled trial. SETTING: 43 outpatient study centres in 11 countries. P...

Popoln opis

Bibliografske podrobnosti

izdano v:	BMJ
Principais autores:	Schumacher, H Ralph, Boice, Judith A, Daikh, David I, Mukhopadhyay, Saurabh, Malmstrom, Kerstin, Ng, Jennifer, Tate, Guillermo A, Molina, Javier
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2002
Teme:	Papers
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12077033/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.324.7352.1488
Oznake:	Označite Brez oznak, prvi označite!